JASPER THERAPEUTICS
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
JASPER THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.jaspertherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
415-946-1087
Email Addresses:
[email protected]
Total Funding:
149.1 M USD
Technology used in webpage:
Euro Microsoft Exchange Online Office 365 Mail IPv6 Gravity Forms WP Engine Zendesk Mimecast Akamai Hosted Zoom Video Conferencing
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Evox Therapeutics
Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Velan Capital
Velan Capital investment in Post-IPO Equity - Jasper Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Post-IPO Equity - Jasper Therapeutics
Woodline Partners
Woodline Partners investment in Post-IPO Equity - Jasper Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Post-IPO Equity - Jasper Therapeutics
Avego Healthcare Capital
Avego Healthcare Capital investment in Post-IPO Equity - Jasper Therapeutics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Jasper Therapeutics
Abingworth
Abingworth investment in Post-IPO Equity - Jasper Therapeutics
Amgen
Amgen investment in Post-IPO Equity - Jasper Therapeutics
Kingdon Capital
Kingdon Capital investment in Post-IPO Equity - Jasper Therapeutics
Apeiron Investment Group
Apeiron Investment Group investment in Post-IPO Equity - Jasper Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-28 | Jasper Therapeutics Announces Appointment of Ronald Martell as Chief Executive OfficerWilliam Lis to Continue as Chairman, Board of Directors |
Official Site Inspections
http://www.jaspertherapeutics.com Semrush global rank: 4.07 M Semrush visits lastest month: 3.01 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Jasper Therapeutics"
Home - Jasper Therapeutics
Leadership Team. Jasper Therapeutics’ management team is composed of experienced biopharma industry veterans with extensive track records in drug development and commercialization.See details»
Team - Jasper Therapeutics
Prior to joining AbbVie, Dr. Brun spent over 15 years at Abbott Laboratories, where he held positions of increasing leadership in drug development within the R&D organization. Ronald Martell In February 2022, Ronald became the CEO …See details»
Jasper Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 650-549-1400 Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for the expanded use of curative therapy with stem cell transplants and …See details»
About Us - Jasper Therapeutics
About Jasper. Jasper is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic for chronic mast and stem cell diseases such as chronic urticaria and lower to …See details»
Jasper Therapeutics - LinkedIn
Jasper Therapeutics | 7,327 followers on LinkedIn. Jasper Therapeutics is a biotechnology company on a mission to make safer and potentially curative therapy possible for more …See details»
Jasper Therapeutics, Inc. (JSPR) Company Profile & Facts - Yahoo …
See the company profile for Jasper Therapeutics, Inc. (JSPR) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Company Profile for Jasper Therapeutics, Inc | Business Wire
Dec 8, 2019 Company: Jasper Therapeutics, Inc Headquarters Address: 3000 Sand Hill Road B1-145 Menlo Park, CA Main Telephone: 1-650-254-6687See details»
Jasper Therapeutics, Inc. (JSPR) Company Profile
Dec 31, 2024 2200 Bridge Pkwy, Suite 102 Redwood City, California 94065 United StatesSee details»
Jasper Therapeutics Company Profile: Overview and Full News …
Jasper Therapeutics is led by a management team with extensive experience in the biopharmaceutical industry, positioning the company well to develop innovative therapies for …See details»
Jasper Therapeutics Corporate Presentation
2 Briquilimab is an investigative drug and is not approved for any indication Safe Harbor Statements Forward-Looking Statements This investor presentation and any accompanying …See details»
Jasper Therapeutics Management Team | Org Chart - RocketReach
Jasper Therapeutics employs 71 employees. The Jasper Therapeutics management team includes Ronald Martell (CEO and President), Matt Ford (Vice President Human Resources), …See details»
JASPER THERAPEUTICS, INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for JASPER THERAPEUTICS, INC of Jasper, TX. Get the latest business insights from Dun & Bradstreet.See details»
Jasper Therapeutics - Craft
Oct 29, 2024 Net income (Q3, 2024)($18.6M) Cash (Q3, 2024)$92.5M EBIT (Q3, 2024)($19.9M) Enterprise value $247.2MSee details»
Jasper Therapeutics Announces Management Changes to
Mar 21, 2022 “These changes will allow us to advance our upcoming pivotal trial of JSP191 in AML/ MDS and execute on our pipeline opportunities with a best-in-class organization,” …See details»
Jasper Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 2200 Bridge Pkwy Suite #102. Redwood City, California, 94065, United States (650) 549-1400See details»
Jasper Therapeutics - Company Profile & Staff Directory
Jasper Therapeutics is a biotechnology company on a mission to make safer and potentially curative therapy possible for more patients in need. We are bringing together a team of …See details»
Jasper Therapeutics - Work in biotech
Jasper Therapeutics develops antibody therapies for stem cell transplants. The company's mission is to make safer and potentially curative therapies possible for more patients in need. …See details»
Jasper Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Www.jaspertherapeutics.com. Public Company | 2018 | California, United States | 10-50 | NASDAQ: JSPR | www.jaspertherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. …See details»
Jasper Therapeutics Announces Health Canada Clearance of …
REDWOOD CITY, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of …See details»
News Release Details - ir.jaspertherapeutics.com
1 day ago Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile Mean change in UAS7 from baseline of -26.6 observed …See details»